research Could Scalp Pain Be a Type of Unclassified Headache?
Scalp pain should be classified as a type of headache.
Search
for
Sort by
Research
30 / 1000+ results 
research Indications for Peripheral and Central Sensitization in Patients With Chronic Scalp Pain (Trichodynia)
Chronic scalp pain in trichodynia involves both body-wide and localized increased pain sensitivity.
research Evaluation of Trichodynia During Chemotherapy or Tamoxifen Treatment in Breast Cancer Patients
Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.
research Cervical Spine Imaging and Treatment Outcomes in Scalp Dysesthesia: A Retrospective Cohort Study
Degenerative changes in the lower cervical spine are common in patients with abnormal scalp sensations, with some improvement seen using pain medication and physical therapy.
research Trichodynia (Scalp Dysesthesia)
Many people with hair loss experience scalp pain known as trichodynia, but the causes are unclear and treatments vary.
research Scalp Dysesthesia: A Study on Chronic Pain and Itchiness
Antidepressants may improve or resolve scalp dysesthesia in most patients.
research Hair Pain (Trichodynia): Frequency and Relationship to Hair Loss and Patient Gender
Hair pain is more common in women with hair loss, but it's not linked to the cause or severity of hair loss.
research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management
COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.
research Management of Chemotherapy-Induced Alopecia With Scalp Cooling
Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.
research Trichodynia Is a Distinguishing Symptom of Telogen Effluvium
Scalp pain is a common symptom in people with active hair loss from telogen effluvium.
research Letters to Dermatology
Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.
research Sensitive Scalp: An Epidemiologic Study in Patients with Hair Loss
Many people with hair loss, especially those with telogen effluvium and alopecia areata, often have a sensitive scalp.
research Scalp Cooling for the Prevention of Chemotherapy-Induced Alopecia: Descriptive Study
Scalp cooling effectively prevents chemotherapy-induced hair loss but requires better pain management.
research Hair Casts
Hair casts are often mistaken for head lice, scalp pain in hair loss is linked to certain nerve factors, eyelash growth treatment is safe and effective, and nail shedding in children may follow hand-foot-mouth disease.
research Successful Treatment of Refractory Trichodynia With Onabotulinumtoxin-A
Onabotulinumtoxin-A effectively treated a painful scalp condition when other treatments failed.
research Trichodynia: A Review of the Literature
Trichodynia is a painful scalp condition linked to hair loss and inflammation, often with anxiety, affecting more women and needing better treatment options.
research Update on Trichodynia, a Challenge for Dermatologists
Trichodynia is a painful scalp condition linked to hair loss and mental health issues, with limited treatment options.
research Trichodynia: An Update on Definition, Etiopathogenesis, Diagnosis, and Treatment
Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.
research Assessment of Depression and Anxiety in Trichodynia Patients of Telogen Effluvium and Alopecia Areata
People with hair loss conditions like Telogen Effluvium and Alopecia Areata often feel scalp pain and are more likely to have anxiety, but not necessarily depression.
research Pathobiology Questions Raised by Telogen Effluvium and Trichodynia in COVID-19 Patients
COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.
research The Role of Psychological Factors and Serum Zinc, Folate, and Vitamin B12 Levels in the Aetiology of Trichodynia: A Case-Control Study
Psychological factors like depression may be more important than zinc, folate, and vitamin B12 levels in causing scalp pain in people with hair loss.
research Effects of Chemical Straighteners on the Hair Shaft and Scalp
Chemical hair straighteners can cause scalp and hair damage, but long-term effects are unclear.
research This Month in JAAD International: November 2021: COVID-19 and Hair Loss
COVID-19 patients often experience temporary hair loss and scalp pain.
research Increased Expression of Nerve Growth Factor and Neurokinin-1 Alarm the Hair Loss in Females with Trichodynia
Higher levels of certain nerve-related proteins are linked to hair loss in women with scalp pain.
research Telogen Effluvium and Trichodynia in Different Severity Groups of Post COVID-19 Patients
Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.
research Early Onset Female Pattern Hair Loss: A Case-Control Study for Analyzing Clinical Features and Genetic Variants
Early onset female hair loss is linked to lower hair density, scalp issues, and certain genetic factors.
research Aching Alopecia: A Case of Giant Cell Arteritis in a 70-Year-Old Woman
Painful hair loss in an elderly woman was caused by giant cell arteritis, not just aging.
research Prevention and Treatment of Chemotherapy-Induced Alopecia: A Narrative Review on Emerging Techniques
Scalp cooling and low-power light therapy show promise in reducing chemotherapy-induced hair loss but need more research.
research Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2
Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.
research Proceedings of the 7th World Congress of Hair Research
The conference discussed various hair disorders and treatments, including the use of topical steroids, high doses of cetrizine, and hair grafting, as well as the psychological impact of hair loss.